IP Library Granted Patent US 8,974,766
Granted Patent B2
US 8,974,766 · App. 13/708,306 · Granted Mar 10, 2015

Labeled alginate conjugates for molecular imaging applications

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,974,766
App. No.
13/708,306
Granted
Mar 10, 2015
Kind
B2
Abstract

Described are bifunctional NOTA-based derivatives capable of conjugating with alginate and with metal ions, as well as NOTA-alginate conjugates which can be labeled with stable or radioactive metal ions. Also described are conjugation methods of the bifunctional NOTA-based linker with alginate, and methods of using radiometal-labeled NOTA-alginate conjugates or other radio-labeled alginate conjugates as imaging reagents.

Claims (25)

1. An alginate conjugate having the formula:

wherein X is —(CH 2 ) m C(O)—, with m being 1, 2, or 3;

L is a linker selected from the group consisting of:

wherein n, n′ and n″ are each independently a number from 0 to 10;

Alg is alginic acid or an alginate salt; and

Y is a spacer directly attached to the reducing end unit of alginate or the carboxyl groups of the alginate polymer chain via the active nitrogen, and has the following structure:

wherein R is selected from the group consisting of hydrogen, alkyl, benzyl or an aromatic group;

or a pharmaceutically acceptable salt or solvate thereof.

2. The alginate conjugate of claim 1 , wherein the conjugate further comprises a stable or radioactive metal ion chelated by the 1,4,7-triazacyclononane-1,4,7-triacetic acid moiety of the conjugate.

3. The alginate conjugate of claim 2 , wherein the stable or radioactive metal ion comprises a gallium ion.

4. The alginate conjugate of claim 2 , wherein the radioactive metal ion comprises 60 Cu, 61 Cu, 62 Cu, 64 Cu, 67 Cu, or 111 In.

5. A method of imaging in a mammal comprising:

administering the alginate conjugate of claim 1 to a mammal; and

imaging the temporal and spatial distribution of the alginate conjugate.

6. The method of claim 5 , wherein the alginate conjugate further comprises a stable or radioactive metal ion chelated by the 1,4,7-triazacyclononane-1,4,7triacetic acid moiety of the conjugate.

7. The method of claim 6 , wherein the stable or radioactive metal ion comprises a gallium ion.

8. The method of claim 6 , wherein the radioactive metal ion comprises 60 Cu, 61 Cu, 62 Cu, 64 Cu, 67 Cu, or 111 In.

9. The method of claim 5 , wherein the alginate conjugated is partially cross-linked.

10. A method of imaging alginate deposition in a mammal comprising:

administering a mixture of and the alginate conjugate of claim 1 and partially calcium-cross-linked alginate to a mammal; and

imaging the temporal and spatial distribution of the alginate conjugate.

11. The method of claim 10 , wherein the alginate conjugate further comprises a stable or radioactive metal ion chelated by the 1,4,7-triazacyclononane-1,4,7-triacetic acid moiety.

12. The method of claim 11 , wherein the stable or radioactive metal ion comprises a gallium ion.

13. The method of claim 11 , wherein the radioactive metal ion comprises 60 Cu, 61 Cu, 62 Cu, 64 Cu, 67 Cu, or 111 In.

14. The method of claim 10 , wherein alginate conjugate is partially cross-linked.

Assignments (4)
CHANGE OF NAME Recorded Mar 14, 2014
From: IKARIA BCM LLC
To: BELLEROPHON BCM LLC
Reel/Frame 032449/0762 →
CHANGE OF NAME Recorded Oct 23, 2013
From: IKARIA DEVELOPMENT SUBSIDIARY ONE LLC
To: IKARIA BCM LLC
Reel/Frame 031479/0757 →
RELEASE OF SECURITY INTEREST Recorded Jul 8, 2013
From: CREDIT SUISSE AG
To: IKARIA DEVELOPMENT SUBSIDIARY ONE LLC
Reel/Frame 030763/0679 →
SECURITY AGREEMENT Recorded Feb 5, 2013
From: IKARIA, INC.; INO THERAPEUTICS LLC; IKARIA DEVELOPMENT SUBSIDIARY ONE LLC
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS COLLATERAL AGENT
Reel/Frame 029759/0692 →